795 Article Views
Publication Date: 12 Sep 2011
Journal: Clinical Medicine Insights: Therapeutics
doi: 10.4137/CMT.S6375
Allergic rhinitis is a common, chronic medical condition affecting millions of people worldwide. Uncontrolled disease has been associated with impairments in quality of life and decreased economic productivity. Proper identification and control of relevant co-morbid conditions is essential for optimal rhinitis control. Management of allergic rhinitis includes identification of relevant allergens, education on avoidance measures, medications and immunotherapy. First-line therapy includes the use on an intranasal steroid. Other treatment options include oral or intranasal antihistamines, decongestants, leukotriene receptor antagonists, mast cell stabilizers or anticholinergic agents. Immunotherapy is an effective treatment option for refractory disease.
Discussion
No comments yet...Be the first to comment.
The editorial staff of Biomarkers in Cancer are very efficient and helpful. I am happy to work with them. I look forward to reviewing future manuscripts.Dr Xi Liu (National Cancer Institute, National Institutes of Health, Bethesda, MD, USA ) What Your Colleagues Say
Copyright © 2012 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)
FacebookGoogle+Twitter
PinterestTumblrYouTube